After announcing an £8bn loss, RBS’s share price has taken a beating. However, as Ed Bowsher explains, that doesn’t mean the bank is worth buying.
Graphene has many special qualities, and huge potential. But who is going to make money from it? David Thornton looks at one small-cap British company aiming to do just that.
People are starting to feel better about Britain’s economy. But there are still some serious problems ahead. Ed Bowsher explains why, and what it means for your investments.
The government looks likely to sell off more assets ahead of the next election. Ed Bowsher looks at what’s on the list, and whether you should buy in.
If you’re tempted to get in on the Royal Mail privatisation, don’t be too quick to part with your money. With IPOs, the odds are stacked against you.
The Chinese government has accused pharma giant GlaxoSmithKline of paying $489m in bribes to doctors and lawyers in order to boost sales and profits.
Looking at the FTSE 100 from a fundamental valuation perspective, there’s every reason to believe it can blast through the 7,000 mark, says Bengt Saelensminde.
The Co-operative Bank is going public in order to stave off nationalisation and plug a £1.5bn capital shortfall.
Stocks, bonds and currencies had another fit of the vapours early this week.
Despite the state that Britain’s economy is in, the FTSE 100 has risen for a record 11 months in a row. Bengt Saelensminde looks at what, if anything, can break this bull market.
Investors have been paying a premium for the safety of investing their money in defensive stocks. But that’s not to say they’ll get it, says Merryn Somerset Webb.